Effects of ginkgolide B on isobaric hypoxic pulmonary hypertension in rats.
D Cheng, W Chen
Abstract
D Cheng, W Chen
Abstract
OBJECTIVE: To evaluate the effects of Ginkgolide B, a specific platelet activating factor (PAF) antagonist, on hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling. MATERIALS AND METHODS: Forty male Wistar rats were divided into 4 groups, receiving normal saline, Ginkgolide B, isobaric hypoxia and isobaric hypoxia plus Ginkgolide B respectively. Pulmonary hemodynamics were assessed via right heart catheterization. Pulmonary vascular remodeling were examined by a computerized image analyser. RESULTS: Chronic hypoxia (FiO2 = 0.10, 3 weeks) caused pulmonary hypertension, pulmonary vascular remodeling and right ventricular hypertrophy in rats. Treatment with Ginkgolide B reduced the extent of pulmonary hypertension, pulmonary vascular remodeling and right ventricular hypertrophy induced by hypoxic exposure. CONCLUSIONS: The results suggest that PAF participates in the process of chronic hypoxic pulmonary hypertension and pulmonary vascular remodeling, and PAF antagonist could be a potentially useful agent for preventing hypoxic pulmonary hypertension.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To evaluate the effects of Ginkgolide B, a specific platelet activating factor (PAF) antagonist, on hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling. MATERIALS AND METHODS: Forty male Wistar rats were divided into 4 groups, receiving normal saline, Ginkgolide B, isobaric hypoxia and isobaric hypoxia plus Ginkgolide B respectively. Pulmonary hemodynamics were assessed via right heart catheterization. Pulmonary vascular remodeling were examined by a computerized image analyser. RESULTS: Chronic hypoxia (FiO2 = 0.10, 3 weeks) caused pulmonary hypertension, pulmonary vascular remodeling and right ventricular hypertrophy in rats. Treatment with Ginkgolide B reduced the extent of pulmonary hypertension, pulmonary vascular remodeling and right ventricular hypertrophy induced by hypoxic exposure. CONCLUSIONS: The results suggest that PAF participates in the process of chronic hypoxic pulmonary hypertension and pulmonary vascular remodeling, and PAF antagonist could be a potentially useful agent for preventing hypoxic pulmonary hypertension.
Key concepts: Pulmonary hypertension, Right ventricular hypertrophy, Hypoxia (environmental), Medicine, Isobaric process, Internal medicine, Cardiology, Muscle hypertrophy